Braskem Owners Finalize Counter Proposal After Rejecting $3B Capital Demand

Key Facts

1Braskem's controlling shareholders are finalizing a counter proposal for creditors after rejecting a demand to inject $3 billion into the producer.

Braskem's controlling shareholders are finalizing a counter proposal for creditors after rejecting a demand to inject $3 billion into the company. Reuters reported that the owners are drafting the alternative offer following a disagreement with lenders over the original terms of the capital injection.

The negotiations over the capital structure remain critical for the petrochemical producer's solvency as owners seek to resolve friction with creditors. BAK closed at $1.55 on October 1, 2026, reflecting the ongoing uncertainty surrounding the firm's debt stabilization efforts.